Europium(III) ion probe spectrofluorometric determination of diclofenac sodium

• Published in: Journal of pharmaceutical and biomedical analysis 1995-10, Vol.13 (11), p.1331-1337
• Main Authors: Carreira, L.A., Rizk, M., El-Shabrawy, Y., Zakhari, N.A., Toubar, S.S.
• Format: Article
• Language: English
• Subjects: Analysis; Anti-Inflammatory Agents, Non-Steroidal - analysis; Biological and medical sciences; Diclofenac - analysis; Diclofenac sodium; Europium; Europium(III) ions; Fluorescent Dyes; General pharmacology; Hydrogen-Ion Concentration; Medical sciences; Pharmaceutical; Pharmacology. Drug treatments; Probe spectrofluorometry; Spectrometry, Fluorescence; Temperature
• ISSN: 0731-7085; 1873-264X
• DOI: 10.1016/0731-7085(95)01567-5

A new method has been devised for the determination of diclofenac sodium in bulk and in pharmaceutical preparations using Eu 3+ ions as the Fluorescent probe. The technique was built around the hypersensitive property of the transitions of the fluorescent probe ion, Eu 3+, at 616 nm. This is normally a forbidden transition, but the interaction with diclofenac sodium, which contains a carboxylic group, makes the transition allowed and enhances the intensity of its fluorescence emission. The Eu 3+ fluorescence emission at 592 nm comes from a non-hypersensitive transition and is not affected by ligation. The intensity ratio, R, defined as I 592/ I 616, was used as a measure of the percentage of bound probe ions. Diclofenac and Eu(III) forms a (1:1) molar complex. The relative stability constant of the complex was found to be 10 5. A linear relationship between bound Eu 3+ and the concentration of diclofenac sodium was found for concentrations from 10 to 200 μg ml −1, with a recovery percentage of 100.22 ± 2.27. The method shows a good agreement with a spectrophotometric method.